TOKYO,March 4,2025-- In a display of global city strategy,the governors of Tokyo and Bangkok have lined up to tackle climate-linked natural disasters,an aging and shrinking population,and other challe
READ MOREBEIJING,March 4,2025--A report from People\'s Daily: Lately,there has been much talk about foreign investors withdrawing from China on a large scale. Official data show that in 2024,foreign direct inv
SINGAPORE,March 5,2025-- Synpulse,a global professional services provider to major banking and financial institutions,is proud to announce the appointment of Nick Wilde as Senior Advisor. Nick\'s exp
SAN FRANCISCO andSUZHOU,China,Jan. 16,2025-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qua
WASHINGTON,Jan. 15,2025-- CGTN America & CCTV UN releases "Prelude to the Spring Festival Gala" hosted by China Media Group returns to New York City
NUC Found Guilty of Patent Infringement,Ordered to Cease Activities,Pay Fines SEOUL,South Korea,Jan. 16,2025-- Hurom,the pioneer of low-speed masticating juicers and a global market leader,has succes
SYDNEY,Jan. 16,2025-- The stage is set for one of Australia\'s most prestigious celebrations of small business excellence!
FORNEBU,Norway,Jan. 16,2025-- Reference is made to the announcement byAker Horizons ASA ("Aker Horizons" or the "Company") on 9 January 2025 regarding fixed income investor meeting
SINGAPORE,Jan. 15,2025--ShengShu Technology,a pioneer in generative video,is introducing a game-changing Vidu 2.0 update for its flagship video generation application Vidu. With 10 million users in ju
PISCATAWAY,N.J.,Jan. 14,2025-- GenScript Biotech Corporation has unveiled an innovation in shipping packaging,propelling GenScript towards achieving their ambitious sustainability goals. The new packa
JINJIANG,China,Jan. 14,2025-- With the rising demand for high-quality footwear and private-label customization,finding the right shoe manufacturer has become a critical challenge for businesses in the
For its third edition,the annual entrepreneurship programme aims to drive change by identifying and supporting women social impact entrepreneurs from South Asia.
SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch
© OfficialAffairs
